06.06.2023 14:45:00
|
Neogen® Launches DNA Test for Beef-on-Dairy Cattle
LINCOLN, Neb., June 6, 2023 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that it has launched Igenity® BeefXDairy, a new and novel leading genomic test for beef-on-dairy calves.
Genetic testing is critical to the efficient management and marketing of beef-on-dairy cattle, and the new Igenity BeefXDairy test provides producers with insight into key traits such as carcass quality, average daily gain, and the Igenity Terminal Index, which can then be used to market the calf's growth potential to buyers. The test will also allow buyers to receive breed composition data (e.g., percentage beef vs. percentage dairy) to help them best manage those cattle for optimal health and maximum growth.
"Neogen is excited to be the first to offer up a commercial genomic tool for this growth cattle market," said Shelby Smith, Bovine Genomics Product Manager at Neogen. "This product offering is a massive step forward in helping to characterize beef-on-dairy animals and allowing dairy producers, cattle buyers, and, ultimately, consumers of beef products to benefit. With increased DNA testing, we can enable improved quality, efficiency, and sustainability within beef production systems."
Neogen Genomics constantly provides high quality data to assist with herd improvement and improve cattle operations, and the new Igenity BeefXDairy test is another tool allowing producers to glean valuable data they need to advance and grow their operations efficiently and sustainably.
To learn more about the new Igenity BeefXDairy test or our other genomics solutions for cattle, contact Neogen by calling 877.443.6589, send an email to genomicsinfo@neogen.com, visit neogen.com, or contact your local Territory Manager.
About Neogen
Neogen Corporation develops and markets comprehensive solutions dedicated to food and animal safety, operating with the intention to "Every day, protect the people and animals we care about." The Company's Food Safety segment markets dehydrated culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases, and sanitation concerns. Neogen's Animal Safety segment is a leader in the development of genomic solutions along with the manufacturing and distribution of a variety of animal healthcare products, including diagnostics, pharmaceuticals, veterinary instruments, wound care, and disinfectants, as well as rodent and insect control solutions.
Contact: Shelby Smith, Bovine Genomics Product Manager
402.435.0665, x7248, SSmith@Neogen.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/neogen-launches-dna-test-for-beef-on-dairy-cattle-301843610.html
SOURCE Neogen Corporation
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Neogen Corp.mehr Nachrichten
12.12.24 |
NASDAQ Composite Index-Wert Neogen-Aktie: So viel hätten Anleger an einem Neogen-Investment von vor einem Jahr verloren (finanzen.at) | |
11.12.24 |
Börse New York in Grün: NASDAQ Composite klettert am Nachmittag (finanzen.at) | |
11.12.24 |
Freundlicher Handel: NASDAQ Composite legt am Mittag zu (finanzen.at) | |
05.12.24 |
NASDAQ Composite Index-Wert Neogen-Aktie: So viel Verlust hätte eine Investition in Neogen von vor 10 Jahren bedeutet (finanzen.at) | |
03.12.24 |
NASDAQ Composite-Handel aktuell: NASDAQ Composite am Mittag im Aufwind (finanzen.at) | |
28.11.24 |
NASDAQ Composite Index-Wert Neogen-Aktie: So viel hätten Anleger an einem Neogen-Investment von vor 5 Jahren verloren (finanzen.at) | |
26.11.24 |
NASDAQ-Handel: NASDAQ Composite notiert am Nachmittag im Plus (finanzen.at) | |
26.11.24 |
Börse New York in Grün: So bewegt sich der NASDAQ Composite am Mittag (finanzen.at) |